Exosome component 1 cleaves single-stranded DNA and sensitizes kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor

Abstract

Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and sensitizes human kidney renal clear cell carcinoma (KIRC) cells to DNA repair inhibitor. Considering that endogenous source of mutation (ESM) constantly assaults genomic DNA and likely sensitize human cancer cells to the inhibitor, we first analyzed the statistical relationship between the expression of individual genes and the mutations for KIRC. Among the candidates, EXOSC1 most notably promoted DNA damages and subsequent mutations via preferentially cleaving C site(s) in single-stranded DNA. Consistently, EXOSC1 was more significantly correlated with C>A transversions in coding strands than these in template strands in human KIRC. Notably, KIRC patients with high EXOSC1 showed a poor prognosis, and EXOSC1 sensitized human cancer cells to poly(ADP-ribose) polymerase inhibitor. These results show that EXOSC1 acts as an ESM in KIRC, and targeting EXOSC1 might be a potential therapeutic strategy.

Data availability

All data associated with this study are available in the main text or the supplementary materials.

The following previously published data sets were used

Article and author information

Author details

  1. Qiaoling Liu

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Qi Xiao

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Zhen Sun

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Bo Wang

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Lina Wang

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Na Wang

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Kai Wang

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Chengli Song

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Qingkai Yang

    Institute of Cancer Stem Cell, DaLian Medical University, DaLian, China
    For correspondence
    yangqingkai@dmu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6628-5393

Funding

National Natural Science Foundation of China (81872310)

  • Qingkai Yang

National Natural Science Foundation of China (82073123)

  • Chengli Song

China Postdoctoral Science Foundation (2020M680956)

  • Lina Wang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Caigang Liu, Shengjing Hospital of China Medical University, China

Version history

  1. Received: April 15, 2021
  2. Accepted: June 21, 2021
  3. Accepted Manuscript published: June 23, 2021 (version 1)
  4. Version of Record published: July 6, 2021 (version 2)

Copyright

© 2021, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 876
    views
  • 124
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Qiaoling Liu
  2. Qi Xiao
  3. Zhen Sun
  4. Bo Wang
  5. Lina Wang
  6. Na Wang
  7. Kai Wang
  8. Chengli Song
  9. Qingkai Yang
(2021)
Exosome component 1 cleaves single-stranded DNA and sensitizes kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
eLife 10:e69454.
https://doi.org/10.7554/eLife.69454

Share this article

https://doi.org/10.7554/eLife.69454

Further reading

    1. Cancer Biology
    2. Cell Biology
    Julian J A Hoving, Elizabeth Harford-Wright ... Alison C Lloyd
    Research Article

    Collective cell migration is fundamental for the development of organisms and in the adult, for tissue regeneration and in pathological conditions such as cancer. Migration as a coherent group requires the maintenance of cell-cell interactions, while contact inhibition of locomotion (CIL), a local repulsive force, can propel the group forward. Here we show that the cell-cell interaction molecule, N-cadherin, regulates both adhesion and repulsion processes during rat Schwann cell (SC) collective migration, which is required for peripheral nerve regeneration. However, distinct from its role in cell-cell adhesion, the repulsion process is independent of N-cadherin trans-homodimerisation and the associated adherens junction complex. Rather, the extracellular domain of N-cadherin is required to present the repulsive Slit2/Slit3 signal at the cell-surface. Inhibiting Slit2/Slit3 signalling inhibits CIL and subsequently collective Schwann cell migration, resulting in adherent, nonmigratory cell clusters. Moreover, analysis of ex vivo explants from mice following sciatic nerve injury showed that inhibition of Slit2 decreased Schwann cell collective migration and increased clustering of Schwann cells within the nerve bridge. These findings provide insight into how opposing signals can mediate collective cell migration and how CIL pathways are promising targets for inhibiting pathological cell migration.

    1. Cancer Biology
    2. Structural Biology and Molecular Biophysics
    Johannes Paladini, Annalena Maier ... Stephan Grzesiek
    Research Article

    Abelson tyrosine kinase (Abl) is regulated by the arrangement of its regulatory core, consisting sequentially of the SH3, SH2, and kinase (KD) domains, where an assembled or disassembled core corresponds to low or high kinase activity, respectively. It was recently established that binding of type II ATP site inhibitors, such as imatinib, generates a force from the KD N-lobe onto the SH3 domain and in consequence disassembles the core. Here, we demonstrate that the C-terminal αI-helix exerts an additional force toward the SH2 domain, which correlates both with kinase activity and type II inhibitor-induced disassembly. The αI-helix mutation E528K, which is responsible for the ABL1 malformation syndrome, strongly activates Abl by breaking a salt bridge with the KD C-lobe and thereby increasing the force onto the SH2 domain. In contrast, the allosteric inhibitor asciminib strongly reduces Abl’s activity by fixating the αI-helix and reducing the force onto the SH2 domain. These observations are explained by a simple mechanical model of Abl activation involving forces from the KD N-lobe and the αI-helix onto the KD/SH2SH3 interface.